TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP)’s traded shares stood at 1.11 million during the last session, with the company’s beta value hitting -0.02. At the close of trading, the stock’s price was $1.62, to imply a decrease of -0.61% or -$0.01 in intraday trading. The TCBP share’s 52-week high remains $523.20, putting it -32196.3% down since that peak but still an impressive 11.73% since price per share fell to its 52-week low of $1.43. The company has a valuation of $0.05M, with an average of 0.28 million shares in intraday trading volume over the past 10 days and average of 257.59K shares over the past 3 months.

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) trade information

After registering a -0.61% downside in the last session, TC BioPharm (Holdings) plc ADR (TCBP) has traded red over the past five days. The 5-day price performance for the stock is -4.71%, and -36.47% over 30 days. With these gigs, the year-to-date price performance is -84.30%. Short interest in TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) saw shorts transact 49374.0 shares and set a 0.11 days time to cover.

TCBP Dividends

TC BioPharm (Holdings) plc ADR has its next earnings report out on 2022-Dec-11. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP)’s Major holders

In total, 0.70% institutions holds shares in the company.

Going by data provided on Aug 31, 2022, Trust For Professional Managers-PMC Diversified Equity Fund holds roughly 19.07 shares. This is just over 0.05% of the total shares, with a market valuation of $30890.0